Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine for chronic refractory angina
ACTRN12611000203954Phase 4Terminated
- Sponsor
- The Queen Elizabeth Hospital
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ivabradine in angina pectoris (2 arms), sponsored by The Queen Elizabeth Hospital. Primary endpoint: Change in Seattle Angina Questionnaire angina frequency score. Started Mar 2011; status: terminated.
02
Drugs
ivabradine
03
Conditions
angina pectoris
Beyond the preview
Go deeper on ACTRN12611000203954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000203954.